MARKET

FLGT

FLGT

Fulgent Genetics
NASDAQ
22.97
-0.03
-0.13%
After Hours: 22.97 0 0.00% 16:10 02/12 EST
OPEN
23.14
PREV CLOSE
23.00
HIGH
23.49
LOW
22.39
VOLUME
268.95K
TURNOVER
--
52 WEEK HIGH
31.04
52 WEEK LOW
14.57
MARKET CAP
710.06M
P/E (TTM)
-16.3884
1D
5D
1M
3M
1Y
5Y
1D
Press Release: Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026
Dow Jones · 10h ago
Fulgent Genetics Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results
Reuters · 10h ago
Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026
Barchart · 16h ago
Weekly Report: what happened at FLGT last week (0202-0206)?
Weekly Report · 3d ago
Fulgent Genetics on Track for Record Losing Streak -- Data Talk
Dow Jones · 02/05 20:12
Weekly Report: what happened at FLGT last week (0126-0130)?
Weekly Report · 02/02 09:51
Tuesday After-Hours Session Sees Broad Gains Across Healthcare And Biotech
NASDAQ · 01/28 03:58
Fulgent Genetics: The Price Has Caught Up To Value, But I Still Like The Stock
Seeking Alpha · 01/27 08:59
More
About FLGT
Fulgent Genetics, Inc. is a technology-based company with a laboratory services business and a therapeutic development business. Its laboratory services business includes technical laboratory and testing services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a novel nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. Its testing services include comprehensive anatomic pathology testing services, including gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology, and precision diagnostics testing services, including next-generation sequencing (NGS), tests for biopharma research and clinical tests for rare disease, hereditary cancer, reproductive health, and many other diseases.

Webull offers Fulgent Genetics Inc stock information, including NASDAQ: FLGT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FLGT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FLGT stock methods without spending real money on the virtual paper trading platform.